• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Aircraft Insulation Market to Reach $9.89 Billion by 2022 - Analysis by Type, Material, Application Area, Platform and Region - Research and Markets

    Aircraft Insulation Market to Reach $9.89 Billion by 2022 - Analysis by Type, Material, Application Area, Platform and Region - Research and Markets

  2. UPDATE: Vertex stock rockets to record, boosting market cap by $8 billion

    UPDATE: Vertex stock rockets to record, boosting market cap by $8 billion

  3. Vertex shares soar 24% to all-time high on cystic fibrosis drug studies

    Vertex shares soar 24% to all-time high on cystic fibrosis drug studies

  4. Rogers to Participate in CJS Summer Conference

    Rogers to Participate in CJS Summer Conference

  5. Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

    Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

  6. Genentech’s Emicizumab Showed Positive Results in Phase III Studies (HAVEN 1 and HAVEN 2) in Hemophilia A With Inhibitors

    Genentech’s Emicizumab Showed Positive Results in Phase III Studies (HAVEN 1 and HAVEN 2) in Hemophilia A With Inhibitors

  7. New Data at EAN Show Genentech’s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures of Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

    New Data at EAN Show Genentech’s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures of Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

12345

©2017 Morningstar Advisor. All right reserved.